Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: Toxicities, histologic response rates, and event-free outcome

Journal of Clinical Oncology

Volumn 20, Issue 10, 2002, Pages 2537-2544

  Pisters, Peter W T ^a   Wolff, Robert A ^a   Janjan, Nora A ^a   Cleary, Karen R ^a   Charnsangavej, Chusilp ^a   Crane, Christopher N ^a   Lenzi, Renato ^a   Vauthey, J Nicolas ^a   Lee, Jeffrey E ^a   Abbruzzese, James L ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PACLITAXEL;

ALLERGIC REACTION; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; FATIGUE; HISTOPATHOLOGY; HUMAN; NAUSEA AND VOMITING; NEUTROPENIA; OUTCOMES RESEARCH; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; PACLITAXEL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PILOT PROJECTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037092960     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.11.064     Document Type: Article

References (37)

1. Cancer of the pancreas
2. Multimodality management of localized pancreatic cancer
3. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival - A prospective, single-institution experience
4. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
5. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group
6. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas
7. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
8. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
9. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study
10. Promotion of microtubule assembly in vitro by Taxol
11. Taxol: A novel radiation sensitizer
12. In vitro studies of Taxol as a radiation sensitizer in human tumor cells
13. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer
14. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck
15. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase I study
16. Paclitaxel and concurrent radiation for gastric cancer
17. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: First feasibility study
18. Preoperative paclitaxel and radiotherapy for locally advanced breast cancer: Surgical aspects
19. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head
20. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy
21. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence
22. Survival following pancreaticoduodenectomy with resection of the superior mesentericportal vein confluence for adenocarcinoma of the pancreatic head
23. The need for standardized pathologic staging of pancreaticoduodenectomy specimens
24. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer. National Cancer Institute of the United States - National Cancer Institute of Canada
25. Nonparametric estimation from incomplete observations
26. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: Clinicopathologic analysis of 5-year survivors
27. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas: Treatment variables and survival duration
28. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy
29. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer
30. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer
31. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer
32. Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines
33. Tables of equivalent dose in 2 Gy fractions: A simple application of the linear quadratic formula
34. Time, dose, and fractionation in radiation therapy: An historical perspective
35. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial
36. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma